US pharmaceutical company to enter the Bulgarian market

US pharmaceutical company "Express diagnostics Int'l. Inc." has decided to start production in Bulgaria and to work on the Bulgarian market. This was announced by company representatives at a meeting with the President of BCCI Tsvetan Simeonov, which was a continuation of the communications in early March this year.

The meeting was attended by Paul Johnson, Executive Director, Gary Jueneman, Senior Executive Vice President and General Manager and Dave Klabunde, Controller and Loucas Luca, Manager of "Cypbul Enterprises" Ltd – a company facilitating the overall impending opening of office and manufacturing facilities of the US company in Sofia.

"Express diagnostics Int'l. Inc." is situated in Minnesota and works in the field of innovative medical diagnostic products and services such as express diagnostics. The company is in the annual ranking of the 5000 fastest-growing companies in the US for 2013 and 2014.

With the forthcoming opening of new production facilities in Bulgaria, the company will officially enter the Bulgarian market. The launch is scheduled for the beginning of 2016. The Company has the intention to supply customers from Europe, Middle East and Africa from Bulgaria.

BCCI has expressed its full support  for the expansion of the US company in the country.